Cargando…

Is Myocardial Infarction in Patients without Significant Stenosis on a Coronary Angiogram as Benign as Believed?

The present study aimed to investigate the clinical characteristics and 1-year outcomes of acute myocardial infarction (AMI) patients without significant stenosis on a coronary angiogram comparison with the clinical characteristics and outcomes of patients with significant coronary artery stenosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Rhew, Shi Hyun, Ahn, Youngkeun, Kim, Min Chul, Jang, Su Young, Cho, Kyung Hoon, Hwang, Seung Hwan, Lee, Min Goo, Ko, Jum Suk, Park, Keun Ho, Sim, Doo Sun, Yoon, Nam Sik, Yoon, Hyun Ju, Kim, Kye Hun, Hong, Young Joon, Park, Hyung Wook, Kim, Ju Han, Jeong, Myung Ho, Cho, Jeong Gwan, Park, Jong Chun, Kang, Jung Chaee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341436/
https://www.ncbi.nlm.nih.gov/pubmed/22570814
http://dx.doi.org/10.4068/cmj.2012.48.1.39
Descripción
Sumario:The present study aimed to investigate the clinical characteristics and 1-year outcomes of acute myocardial infarction (AMI) patients without significant stenosis on a coronary angiogram comparison with the clinical characteristics and outcomes of patients with significant coronary artery stenosis. A total of 1,220 patients with AMI were retrospectively classified into Group I (≥50% diameter stenosis, n=1,120) and Group II (<50%, n=100). Group II was further divided into two subgroups according to the underlying etiology: cryptogenic (Group II-a, n=54) and those with possible causative factors (Group II-b, n=46). Patients in Group II were younger, were more likely to be women, and were less likely to smoke and to have diabetes mellitus than were patients in Group I. The levels of cardiac enzymes, LDL-cholesterol levels, and the apo-B/A1 ratio were lower in Group II. However, 1-month and 12-month rates of major adverse cardiac events (MACE) were not significantly different between the two groups. The Group II-b subgroup comprised 29 patients with vasospasm, 11 with myocardial bridge, and 6 with spontaneous thrombolysis. Left ventricular ejection fraction and creatinine clearance were lower and levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hs-CRP) were higher in Group II-a than in Group II-b. However, outcomes including MACE and mortality at 12 months were not significantly different between the two subgroups. The 1-year outcomes of patients in Group II were similar to those of patients in Group I. The clinical outcomes in Group II-a were also similar to those of Group II-b, although the former group showed higher levels of NT-proBNP and hs-CRP.